< Back to Find a Trial

Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4 Study)

ID

NCT02008357

Condition Studied

Healthy “at risk”

Phase

Phase III

Status

Closed

Intervention

Solanezumab

Principal Investigator

Julio Rojas, MD, PhD

[email protected]

Please go to https://a4study.org/ and ClinicalTrials.gov for more information.